Hemogenyx Pharmaceuticals Plc Stock Market Value
| HOPHF Stock | USD 0 0.00 0.00% |
| Symbol | Hemogenyx |
Hemogenyx Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Hemogenyx Pharmaceuticals' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Hemogenyx Pharmaceuticals.
| 10/24/2024 |
| 11/23/2024 |
If you would invest 0.00 in Hemogenyx Pharmaceuticals on October 24, 2024 and sell it all today you would earn a total of 0.00 from holding Hemogenyx Pharmaceuticals Plc or generate 0.0% return on investment in Hemogenyx Pharmaceuticals over 30 days. Hemogenyx Pharmaceuticals is related to or competes with Zenith Capital, ProMIS Neurosciences, Fennec Pharmaceuticals, Eliem Therapeutics, Inhibrx, Celcuity LLC, and Enliven Therapeutics. Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and com... More
Hemogenyx Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Hemogenyx Pharmaceuticals' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Hemogenyx Pharmaceuticals Plc upside and downside potential and time the market with a certain degree of confidence.
Hemogenyx Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Hemogenyx Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Hemogenyx Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Hemogenyx Pharmaceuticals historical prices to predict the future Hemogenyx Pharmaceuticals' volatility.Hemogenyx Pharmaceuticals Backtested Returns
We have found three technical indicators for Hemogenyx Pharmaceuticals, which you can use to evaluate the volatility of the firm. The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Hemogenyx Pharmaceuticals are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
Hemogenyx Pharmaceuticals Plc has perfect predictability. Overlapping area represents the amount of predictability between Hemogenyx Pharmaceuticals time series from 24th of October 2024 to 8th of November 2024 and 8th of November 2024 to 23rd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Hemogenyx Pharmaceuticals price movement. The serial correlation of 1.0 indicates that 100.0% of current Hemogenyx Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Hemogenyx Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Hemogenyx Pharmaceuticals pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Hemogenyx Pharmaceuticals' pink sheet expected returns. We can calculate the autocorrelation of Hemogenyx Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Hemogenyx Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Hemogenyx Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Hemogenyx Pharmaceuticals pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Hemogenyx Pharmaceuticals pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Hemogenyx Pharmaceuticals pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Hemogenyx Pharmaceuticals Lagged Returns
When evaluating Hemogenyx Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Hemogenyx Pharmaceuticals pink sheet have on its future price. Hemogenyx Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Hemogenyx Pharmaceuticals autocorrelation shows the relationship between Hemogenyx Pharmaceuticals pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Hemogenyx Pharmaceuticals Plc.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Hemogenyx Pink Sheet
Hemogenyx Pharmaceuticals financial ratios help investors to determine whether Hemogenyx Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hemogenyx with respect to the benefits of owning Hemogenyx Pharmaceuticals security.